RECALLS AND SAFETY ALERTS CARDIOVASCULAR RISK WITH MERIDIA

April 8, 2010

FDA is alerting healthcare professionals that Meridia (sibutramine) is contraindicated in patients with a history of cardiovascular disease because the drug increases their risk of heart attack and stroke. Meridia is used to manage obesity. In ...

Full Story Below

Rapid Response
Free Case Evaluation

The Help You Need,
When You Need it Most

Area of Law
First Name
Last Name
Phone
Email
Zip Code
Case Specifics
Please Type The Number You See Below
9976

More from FDA News Directory

lawyercen

New from FDA Help FDA Stop Bad Ads..

lawyercen

Advice for Patients Phase-Out of CFC Inhalers..

lawyercen

Advice for Patients Caution about Sexual Enhancement Supplements..

lawyercen

Preventing Medical Errors Avoiding Problems with Temporary Cardiac Pacing..

lawyercen

Recalls and Safety Alerts Hemolysis Risk with WinRho SDF..

lawyercen

Recalls and Safety Alerts Boxed Warning for Exjade..

lawyercen

Recalls and Safety Alerts Companies to Stop Marketing Unapproved Nitroglyce..

lawyercen

Recalls and Safety Alerts Muscle Injury from High Doses of Zocor..

lawyercen

Recalls and Safety Alerts Reduced Effect from Plavix in Some Patients..

lawyercen

New Medical Products First Absorbable Sealant Patch for Cardiovascular Surg..

lawyercen

New Medical Products New Formulation for OxyContin..

lawyercen

Advice for Patients Avoiding Maalox Mix-ups..

lawyercen

Recalls and Safety Alerts Risk Management Program for Procrit, Epogen and A..

lawyercen

Recalls and Safety Alerts Reducing the Risk of Overfill with HomeChoice Per..

lawyercen

Recalls and Safety Alerts Review of Invirase and Cardiac Arrhythmias..

RECALLS AND SAFETY ALERTS CARDIOVASCULAR RISK WITH MERIDIA

April 8, 2010

Rapid Response Free Case Evaluation

The Help You Need, When You Need it Most

9976

More from FDA News Directory

Rapid Response
Free Case Evaluation

The Help You Need,
When You Need it Most